4-Nitroquinoline 1-oxide: Difference between revisions
Jump to navigation
Jump to search
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
Line 9: | Line 9: | ||
* [http://jamesline.com/cancertypes/glossary/index.cfm?action=Display&ID=367451&Letter=1 4-NQO] in [http://jamesline.com/cancertypes/glossary/ NCI Dictionary from PDQ] (2004). Verified availability 2005-03-19. | * [http://jamesline.com/cancertypes/glossary/index.cfm?action=Display&ID=367451&Letter=1 4-NQO] in [http://jamesline.com/cancertypes/glossary/ NCI Dictionary from PDQ] (2004). Verified availability 2005-03-19. | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Carcinogens]] | [[Category:Carcinogens]] |
Latest revision as of 15:17, 17 August 2015
Overview
4-nitroquinoline 1-oxide (also known as 4-NQO, 4NQO, 4Nqo and NQO) is a tumorigenic compound used in the assessment of the efficacy of diets, drugs, and procedures in the prevention and treatment of cancer in animal models.
References
- 4-NQO in NCI Dictionary from PDQ (2004). Verified availability 2005-03-19.